Wrong again. it's really not hard to find this information out. Perhaps you should spend a minute or two researching for accurate information before spouting off like you know what you're talking about, embarrassing yourself yet again. Sometimes I wonder how you stay employed, between chronically being wrong and your trolling personality. Merck discovered lovastatin. Period, as per the excerpt/article below.
In 1978, Alfred Alberts, along with his colleagues at Merck Research Laboratories, discovered a potent inhibitor of HMG-CoA reductase in a fermentation broth of Aspergillus terreus, which was named lovastatin, mevinolin or monacolin K.
https://www.news-medical.net/health/Statin-History.aspx#:~:text=In 1978, Alfred Alberts, along,lovastatin, mevinolin or monacolin K.
Merck did not discover the statin class, obviously, but in addition to being first to market with a cholesterol lowering statin, Merck also was the first company to demonstrate that lowering cholesterol actually led to significantly beneficial outcomes, via the landmark 4S study, which, in 1994, showed significant reduction in recurrent heart attacks (as per the excerpt/link below). This is what opened the floodgates in the statin world.
The trial results led to FDA approval in 1987, but Merck had to stipulate in its product label that no clinical outcome benefit could be inferred from those findings—all they could say was that statin safely lowered LDL cholesterol levels in blood. Only when the results of a landmark clinical trial (4S) were unveiled in 1994, revealing that lowering of LDL cholesterol significantly reduced the recurrence of heart attacks (secondary prevention), was the association between cholesterol reduction by statins and the inhibition of cardiovascular events established (Scandinavian Simvastatin Survival Group, 1994).
https://www.cell.com/fulltext/S0092-8674(08)01127-6